Tag Cloud

What is a tag cloud?

Current tags: Clear current tags
View full tag cloud
Advertisement
Q

What is the evidence for prescribing Celluvisc (Carmellose) over products such as hypromellose for dry eye syndrome?

Associated tags: carmellose, comparative effectiveness, dry eye syndrome, Ophthalmology

Question DetailsView Comments (0)
A

ANSWER

provided by Trip / NLH
Search
Moderate
Appraisal
Moderate
Confidence
Moderate

Answer Rating key

search strong
appraisal weak
confidence moderate

Question answered:09/04/08

We could find no evidence to recommend prescribing carmellose over other products for dry eye syndrome.

 

CKS have a guideline on dry eye syndrome [1], this does not recommend Carmellose over other products. 

 

We searched for comparative trials with other products and were unable to find any.

 

Reference

1) http://www.cks.library.nhs.uk/dry_eye_syndrome/view_whole_guidance
 

 

 

DISCLAIMER: TRIPanswers is a collection of clinical questions and answers.  Each provider will have their own methodology in answering questions and these are likely not to be as rigorous as systematic review.  If you have any doubt as to the implications of this contact the Q&A Service Provider for further information. This document is presented for information purposes only. This document cannot and should not be used as a basis of diagnosis or choice of treatment, and is in no way intended to replace professional medical care or attention by a qualified practitioner. TRIPanswers and TRIP Database Ltd are not responsible or liable for, directly or indirectly, ANY form of damage whatsoever resulting from the use/misuse of information contained in or implied by this document.  Also, ensure you have read the terms and conditions for using the site.

Need to search for more evidence?

Help us improve this answer

Leave comments or suggestions below

Disclaimer:

TRIP will review each comment and will only publish those we feel will enhance a particular answer.  As a result of the review process there will be a delay between submission and publication of accepted comments.